Drug intelligence / Profile preview

perilla frutescens leaf ethanol extract

Development stage
Unknown
Lead developer
S&D production facility
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Perilla frutescens leaf ethanol extract is a **botanical small-molecule mixture** derived from the leaves of *Perilla frutescens* using ethanol extraction, typically standardized as a nutraceutical or research extract rather than a single defined pharmaceutical active ingredient. Reported constituents include rosmarinic acid, luteolin, perillaldehyde, caffeic acid, and other phenolic compounds. Across preclinical studies, the extract has shown multimodal bioactivity including inhibition of Src-mediated epithelial-mesenchymal transition and cancer cell migration, suppression of inflammatory signaling pathways such as NF-kB with downstream reduction of cytokines including IL-6 and TNF-a, and inhibition of enzymes implicated in cognitive impairment and Alzheimer disease such as acetylcholinesterase and beta-secretase 1. A randomized clinical study has evaluated an oral standardized 60 percent ethanol extract at 500 mg daily for cognitive impairment. The asset appears to be a non-branded botanical development or nutraceutical ingredient associated with academic research and Korean standardization efforts including S&D rather than a marketed prescription drug product.

Other names
perilla leaf ethanol extractethanol extract of Perilla frutescens leavesPerilla frutescens leaf extract
02

Targets

AcetylcholinesteraseTNFRSF1A (Tumor necrosis factor receptor superfamily member 1A)SRC (Proto-oncogene tyrosine-protein kinase Src)

Beyond the preview

Go deeper on perilla frutescens leaf ethanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perilla frutescens leaf ethanol extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call